Will a re-emergence of ancient infectious diseases pose a new risk to humanity in the coming millennia?

Author:

Tulp, PhD, MD, FACN, CNS Orien L

Abstract

Infectious diseases including smallpox, the black plague, cholera, and others have been responsible for the loss of millions of lives over the past millennia, prior to the development of effective treatment strategies during the recent century. Throughout history, epidemics and pandemics are known to have occurred intermittently throughout the world for over 2,500 years. During the 20th century, many of the causative infectious agents were identified, the evolution of vaccines and antimicrobials were developed, resulting in treatment strategies and public health measures that brought about the resolution and presumed virtual eradication of some of the infectious agents. Cholera is transmitted via the fecal-oral route, and outbreaks continue to occur, with the most recent epidemic in Haiti following the massive earthquake of 2010 despite the development of effective vaccines and supporting public health measures. While smallpox was deemed to have been eradicated by the WHO, the recent discovery of Alaskapox, a novel strain of orthopoxvirus that is genetically similar to ‘old-world’ smallpox claimed its first fatality in January 2024. The bubonic plague also continues to reappear in clusters, most recently in rural Oregon in the USA in early 2024. Thus, the emergence of variants of these and other devastating ancient diseases continues to require diligence in establishing and delivery of public health measures and therapeutic options to ensure the plagues of former millennia remain in the history books and not in the community during the present and future generations.

Publisher

MedCrave Group, LLC

Reference22 articles.

1. The history of infectious diseases and medicine;Sakai;Pathogens,2022

2. Tulp O L, Einstein GP. Efficacy of biophotonics as a therapeutic option in resolving microbial and viral infectious diseases. Enliven: Immunology and Immunotechniques 2024.

3. Noh JY, Jeong HW, Shin EC. SARS-CoV-2 mutations, vaccines, and immunity. Implication of variants of concern. 2021.

4. CDC Centers for disease prevention and control. Omicron Variant: What You Need to Know. 2021.

5. Elflein J. Coronavirus (COVID-19) in the U.S. - Health, Pharma & Medtech Statistics & Facts, Statistica, 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3